Novel derivatives of 3-alkyl-1,5-diaryl-1H-1,2,4-triazoles and their pharmacological evaluation as CB1 cannabinoid ligands

This publication has 14 references indexed in Scilit:

• Therapeutic opportunities through modulation of the endocannabinoid system
  Neuropharmacology, 2005
• Keynote review: Medicinal chemistry strategies to CB1 cannabinoid receptor antagonists
  Drug Discovery Today, 2005
• Discovery of 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole, a Novel in Vivo Cannabinoid Antagonist Containing a 1,2,4-Triazole Motif
  Journal of Medicinal Chemistry, 2004
• Cannabinoid physiology and pharmacology: 30 years of progress
  Neuropharmacology, 2004
• Cannabinergic ligands
  Chemistry and Physics of Lipids, 2002
• International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
  Pharmacological Reviews, 2002
• Cannabinoid receptors and their ligands
  Prostaglandins, Leukotrienes and Essential Fatty Acids, 2002
• Cyclization of 1,2,4-triazenes to 1,2,4-triazoles using oxidizing reagents—NaClO, Ca(ClO)2, Dess–Martin periodinane and Ley's TPAP/NMO
  Tetrahedron, 2001
• An Improved Synthesis of 1,2,4-Triazoles using Ag2CO3
  Tetrahedron, 2000
• Facile synthesis of hydrazonyl halides by reaction of hydrazones with N-halosuccinimide-dimethyl sulfide complex
  Tetrahedron, 1996